Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus

被引:15
|
作者
Lu, Xiuhua [1 ]
Liu, Feng [1 ]
Zeng, Hui [1 ]
Sheu, Tiffany [1 ]
Achenbach, Jenna E. [1 ]
Veguilla, Vic [1 ]
Gubareva, Larisa V. [1 ]
Garten, Rebecca [1 ]
Smith, Catherine [1 ]
Yang, Hua [1 ]
Stevens, James [1 ]
Xu, Xiyan [1 ]
Katz, Jacqueline M. [1 ]
Tumpey, Terrence M. [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA
关键词
Influenza virus; Anti-neuraminidase antibodies; Antigenic and genetic analyses; Passive immunization; BALB/c mice; Cross-protective immunity; 3-DIMENSIONAL STRUCTURE; VIRAL NEURAMINIDASE; ANTIBODY-RESPONSES; CRYSTAL-STRUCTURES; LETHAL INFLUENZA; VACCINE; H3N2; HEMAGGLUTININ; INFECTION; SEQUENCE;
D O I
10.1016/j.virol.2014.02.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To determine the genetic and antigenic relatedness as well as the cross-protective immunity of human HI NI and avian H5N1 influenza virus neuraminidase (NA), we immunized rabbits with either a baculovirus-expressed recombinant NA from A/Beijing/262/95 (BJ/262) H1N1 or A/Hong Kong/483/97 (HK/483) H5N1 virus. Cross-reactive antibody responses were evaluated by multiple serological assays and cross-protection against H5N1 virus challenge was evaluated in mice. In a neuraminidase inhibition (NI) test, the antisera exhibited substantial inhibition of NA activity of the homologous virus, but failed to inhibit the NA activity of heterologous virus. However, these antisera exhibited low levels of cross-reactivity measured by plaque size reduction, replication inhibition, single radial hemolysis, and ELISA assays. Passive immunization with HK/483 NA-specific antisera significantly reduced virus replication and disease, and afforded almost complete protection against lethal homologous virus challenge in mice. However, passive immunization with BJ/262 (H1N1) NA-specific antisera was ineffective at providing cross-protection against lethal H5N1 virus challenge and only slightly reduced weight loss. Substantial amino acid variation among the NA antigenic sites was observed between BJ/262 and HK/483 virus, which was consistent with the lack of cross-reactive NI activity by the antibody and limited cross-protective immunity in mice. These results show a strong correlation between the lack of cross-protective immunity and low structural similarities of NA from a human seasonal HI NI virus and an avian H5N1 influenza virus. Published by Elsevier Inc
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [41] Phylodynamics of H5N1 avian influenza virus in Indonesia
    Lam, Tommy Tsan-Yuk
    Hon, Chung-Chau
    Lemey, Philippe
    Pybus, Oliver G.
    Shi, Mang
    Tun, Hein Min
    Li, Jun
    Jiang, Jingwei
    Holmes, Edward C.
    Leung, Frederick Chi-Ching
    MOLECULAR ECOLOGY, 2012, 21 (12) : 3062 - 3077
  • [42] Risk assessment of a highly pathogenic H5N1 influenza virus from mink
    Restori, Katherine H.
    Septer, Kayla M.
    Field, Cassandra J.
    Patel, Devanshi R.
    Vaninsberghe, David
    Raghunathan, Vedhika
    Lowen, Anice C.
    Sutton, Troy C.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [43] Characterization of Neuraminidases from the Highly Pathogenic Avian H5N1 and 2009 Pandemic H1N1 Influenza A Viruses
    Wu, Jia
    Zhang, Fengwei
    Wang, Maorong
    Xu, Chunqiong
    Song, Jingdong
    Zhou, Jianfang
    Lin, Xiaojing
    Zhang, Yonghui
    Wu, Xiaobing
    Tan, Wenjie
    Lu, Jian
    Zhao, Honglan
    Gao, Jimin
    Zhao, Ping
    Lu, Jianxin
    Wang, Yue
    PLOS ONE, 2010, 5 (12):
  • [44] Induction of Cross-Protective Immunity Against Influenza A Virus H5N1 by an Intranasal Vaccine With Extracts of Mushroom Mycelia
    Ichinohe, Takeshi
    Ainai, Akira
    Nakamura, Tomoyuki
    Akiyama, Yukihito
    Maeyama, Jun-ichi
    Odagiri, Takato
    Tashiro, Masato
    Takahashi, Hidehiro
    Sawa, Hirofumi
    Tamura, Shin-ichi
    Chiba, Joe
    Kurata, Takeshi
    Sata, Tetsutaro
    Hasegawa, Hideki
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (01) : 128 - 137
  • [45] Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus
    Kreijtz, J. H. C. M.
    Bodewes, R.
    van den Brand, J. M. A.
    de Mutsert, G.
    Baas, C.
    van Amerongen, G.
    Fouchier, R. A. M.
    Osterhaus, A. D. M. E.
    Rimmelzwaan, G. F.
    VACCINE, 2009, 27 (36) : 4983 - 4989
  • [46] Isolation and characterization of highly pathogenic avian influenza virus subtype H5N1 from donkeys
    Ahmed S Abdel-Moneim
    Ahmad E Abdel-Ghany
    Salama AS Shany
    Journal of Biomedical Science, 17
  • [47] Pathogenicity, Transmission and Antigenic Variation of H5N1 Highly Pathogenic Avian Influenza Viruses
    Jiao, Peirong
    Song, Hui
    Liu, Xiaoke
    Song, Yafen
    Cui, Jin
    Wu, Siyu
    Ye, Jiaqi
    Qu, Nanan
    Zhang, Tiemin
    Liao, Ming
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [48] Evaluation of a rapid test for detection of H5N1 avian influenza virus
    Chen, Yixin
    Xu, Feihai
    Fan, Xiaohui
    Luo, Haifeng
    Ge, Shenpiang
    Zheng, Qingbing
    Xia, Ningshao
    Chen, Honglin
    Guan, Yi
    Zhang, Jun
    JOURNAL OF VIROLOGICAL METHODS, 2008, 154 (1-2) : 213 - 215
  • [49] An H5N1 highly pathogenic avian influenza virus that invaded Japan through waterfowl migration
    Kajihara, Masahiro
    Matsuno, Keita
    Simulundu, Edgar
    Muramatsu, Mieko
    Noyori, Osamu
    Manzoor, Rashid
    Nakayama, Eri
    Igarashi, Manabu
    Tomabechi, Daisuke
    Yoshida, Reiko
    Okamatsu, Masatoshi
    Sakoda, Yoshihiro
    Ito, Kimihito
    Kida, Hiroshi
    Takada, Ayato
    JAPANESE JOURNAL OF VETERINARY RESEARCH, 2011, 59 (2-3) : 89 - 100
  • [50] Neurotropic Highly Pathogenic Avian Influenza A(H5N1) Virus in Red Foxes, Northern Germany
    Baechlein, Christine
    Kleinschmidt, Sven
    Hartmann, Dorothee
    Kammeyer, Patricia
    Woehlke, Anne
    Warmann, Tobias
    Herms, Louise
    Kuehl, Bianca
    Beineke, Andreas
    Wohlsein, Peter
    Harder, Timm
    Runge, Martin
    EMERGING INFECTIOUS DISEASES, 2023, 29 (12) : 2509 - 2512